A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Conditions
Glioblastoma Multiforme · Recurrent Glioblastoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama Birmingham, Birmingham, Alabama, United States
University of California San Diego, San Diego, California, United States
Contact: Principal Investigator (Zachary Berman, MD)University of California San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Nicholas Butowski, MD)Mayo Jacksonville, Jacksonville, Florida, United States
Contact: Principal Investigator (Alfredo Quinones-Hinojosa, MD)Northwestern Univerity, Chicago, Illinois, United States
Contact: Principal Investigator (Samdeep Mouli, MD)Johns Hopkins Interventional Radiology Center, Baltimore, Maryland, United States
Washington University School of Medicine, St Louis, Missouri, United States
Contact: Principal Investigator (Arindam Chatterjee, M.D.)Lenox Hill Hospital, New York, New York, United States
Contact: Principal Investigator (John Boockvar, MD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Stephen Chen, MD)
Study leads
Riad Salem, M.D.
Principal Investigator
Northwestern University
Roger Stupp, M.D.
Principal Investigator
Northwestern University